Nutralife Biosciences Inc
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutrace… Read more
Market Cap & Net Worth: Nutralife Biosciences Inc (NLBS)
Nutralife Biosciences Inc (PINK:NLBS) has a market capitalization of $17.66K ($17.66K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45031 globally and #14199 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nutralife Biosciences Inc's stock price $0.00 by its total outstanding shares 176623008 (176.62 Million).
Nutralife Biosciences Inc Market Cap History: 2015 to 2024
Nutralife Biosciences Inc's market capitalization history from 2015 to 2024. Data shows change from $17.66 Million to $17.66K (-57.41% CAGR).
Nutralife Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nutralife Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
21.70x
Nutralife Biosciences Inc's market cap is 21.70 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $17.66 Million | $194.00K | -$2.10 Million | 91.04x | N/A |
| 2016 | $67.12 Million | $391.86K | -$1.53 Million | 171.28x | N/A |
| 2017 | $116.57 Million | $1.79 Million | -$23.63 Million | 65.12x | N/A |
| 2018 | $35.06 Million | $3.71 Million | -$2.07 Million | 9.45x | N/A |
| 2019 | $13.25 Million | $2.13 Million | -$4.01 Million | 6.21x | N/A |
| 2020 | $16.78 Million | $1.26 Million | -$2.90 Million | 13.36x | N/A |
| 2021 | $13.60 Million | $626.62K | -$7.68 Million | 21.70x | N/A |
Competitor Companies of NLBS by Market Capitalization
Companies near Nutralife Biosciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Nutralife Biosciences Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Nutralife Biosciences Inc Historical Marketcap From 2015 to 2024
Between 2015 and today, Nutralife Biosciences Inc's market cap moved from $17.66 Million to $ 17.66K, with a yearly change of -57.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $17.66K | -50.00% |
| 2023 | $35.32K | -99.38% |
| 2022 | $5.65 Million | -58.44% |
| 2021 | $13.60 Million | -18.95% |
| 2020 | $16.78 Million | +26.67% |
| 2019 | $13.25 Million | -62.22% |
| 2018 | $35.06 Million | -69.92% |
| 2017 | $116.57 Million | +73.68% |
| 2016 | $67.12 Million | +280.00% |
| 2015 | $17.66 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 28th, 2025 the market cap of Nutralife Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.66K USD |
| MoneyControl | $17.66K USD |
| MarketWatch | $17.66K USD |
| marketcap.company | $17.66K USD |
| Reuters | $17.66K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.